To analyze the clinical feasibility and effectiveness of holographic three-dimensional visualization assisted laparoscopic adrenal tumor resection, and to evaluate the effect of doctor-patient communication

A total of 72 patients who underwent laparoscopic adrenal tumor resection for adrenal tumors from January 2018 to December 2022 were collected. Inclusion criteria were as follows: adrenal benign lesions, body mass index < 30 kg/m², maximum tumor diameter < 8 cm, and American Society of Anesthesiologists (ASA) gradeⅠ or Ⅱ. There were 32 cases who received holographic three-dimensional visualization technology before surgery (observation group), and 40 patients who did not receive holographic three-dimensional visualization technology before surgery (control group). There were no significant differences between the observation group and the control group in gender, age, BMI, tumor diameter, tumor side and complicated diseases (P>0.05). Both groups underwent 64-slice spiral CT plain scan + enhanced scan before surgery. In the observation group, 3D visual digital models and holograms were reconstructed from the CT images, which were used for preoperative planning, doctor-patient communication and intraoperative navigation. Patients in both groups completed the questionnaire of disease awareness and preoperative communication satisfaction. The following indexes were compared between the two groups: scores of patients’ disease awareness and preoperative communication satisfaction questionnaire, and data about perioperative relevant indicators.

All operations were successfully completed. The operative time, intraoperative blood loss, tumor rupture cases and intraoperative drainage indwelling time in the observation group were lower than those in the control group, respectively [(53.5±17.9) min vs. (63.9±19.2) min, F=5.552; (45.8±7.2) ml vs. (49.4±6.6) ml, F=4.623; 0 cases vs. 5 cases; (2.5±0.4) d vs. (2.8±0.6) d, F=6.340], the differences were statistically significant (P<0.05). Postoperative recovery time of intestinal peristalsis [(1.5±0.7) d vs. (1.6±0.8) d], indwelling time of urinary catheter [(1.8±0.4) d vs. (1.9±0.5) d], time of postoperative bed stay [(1.6±0.4) d vs. (1.7±0.4) d], pathological type and length of hospital stay [(4.6±0.5) d vs. (4.7±0.6) d] showed no significant difference between two groups (P>0.05). The time spent signing the consent form during the preoperative interview in the observation group and the control group was [(23.9±1.1) min vs. (25.2±2.6) min], understanding degree of tumor condition [(7.8±0.4) points vs. (7.6±0.3) points], understanding degree of surgical plan and complications [(7.9±0.5) points vs. (7.5±0.4) points], satisfaction degree of doctors’ preoperative interview effect [(7.9±0.4) min vs. (7.6±0.2) min] showed statistically significant difference (P<0.05).

Holographic 3D visualization technology to assist adrenal tumor surgical treatment and doctor-patient communication can reduce the operation time, reduce the risk of surgery, improve patients’ cognition and understanding of their own disease and surgery, and increase the effect of doctor-patient communication.

Adrenal tumor; Hologram imaging; 3D visualization; Tumor resection; Doctor-patient communication